Business modelsB2B

Products 21 to 30 of 162

Bio-DEMâ„¢ by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Enzyme + Gene Editing + Microbe + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:33 (5 years ago)
Date last modified: 2019/09/12 14:33 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment + Venture Capital
Industry: Industrial + Multipurpose
Market status: On the market
Organization type(s): Private Company
Product categories: Additive + Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:28 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
BIO-SA Based Phthalate-Free Plasticizers by LANXESS + BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Germany
Country of distribution: USA + Germany
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/09 16:28 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: LXS (XETRA)
Value chain stage: N/A
BIO-SA Based Polyurethanes by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:29 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
BIO-SA Brand Flavor Enhancers by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:31 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: Canada + France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:32 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
bioCement by bioMason
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:47 (5 years ago)
Known funding amount: 2,800,000 USD
Funding types: Foundation + Government + University + Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Gene Editing
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 16:57 (5 years ago)
Known funding amount: 250,000 USD
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Bioengineered mRNA for gene therapy by University of Wisconin-Madison
Biotech components: Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:36 (3 years ago)
Date last modified: 2020/12/18 14:36 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Biotech components: Enzyme + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (3 years ago)
Date last modified: 2020/12/18 14:38 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): University
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product